Kit Ligand and Kit receptor tyrosine kinase sustain synaptic inhibition of Purkinje cells

被引:1
|
作者
Zaman, Tariq [1 ]
Vogt, Daniel [1 ]
Prokop, Jeremy [2 ]
Alsabia, Qusai Abdulkhaliq [1 ]
Simms, Gabriel [1 ]
Stafford, April [1 ]
Luikart, Bryan W. [3 ]
Williams, Michael R. [1 ]
机构
[1] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, E Lansing, MI 48912 USA
[2] Corewell Hlth, Off Res, Grand Rapids, MI USA
[3] Dartmouth Coll, Dept Mol & Syst Biol, Geisel Sch Med, Hanover, NH USA
来源
ELIFE | 2024年 / 12卷
基金
美国国家卫生研究院;
关键词
cerebellum; synapse; trans-synaptic; interneuron; receptors; development; Mouse; DOMINANT PIEBALD TRAIT; C-KIT; CEREBELLAR CORTEX; PHOSPHOLIPASE-C-BETA-4; EXPRESSION; GABAERGIC INTERNEURONS; POSTNATAL-DEVELOPMENT; RETARDED-CHILD; RAT; COLLATERALS; SYNAPSES;
D O I
10.7554/eLife.89792
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Tyrosine Kinase Inhibition in Mastocytosis KIT and Beyond KIT
    Bibi, Siham
    Arock, Michel
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (03) : 527 - +
  • [2] Expression of the receptor tyrosine kinase KIT in mature β-cells and in the pancreas in development
    Rachdi, L
    El Ghazi, L
    Bernex, F
    Panthier, JJ
    Czernichow, P
    Scharfmann, R
    DIABETES, 2001, 50 (09) : 2021 - 2028
  • [3] Inhibition of c-Kit by tyrosine kinase inhibitors
    Galanis, Allison
    Levis, Mark
    HAEMATOLOGICA, 2015, 100 (03) : E77 - E79
  • [4] Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
    Heinrich, MC
    Griffith, DJ
    Druker, BJ
    Wait, CL
    Ott, KA
    Zigler, AJ
    BLOOD, 2000, 96 (03) : 925 - 932
  • [5] A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase
    Zhi-Chao Feng
    Matthew Riopel
    Alex Popell
    Rennian Wang
    Diabetologia, 2015, 58 : 654 - 665
  • [6] A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase
    Feng, Zhi-Chao
    Riopel, Matthew
    Popell, Alex
    Wang, Rennian
    DIABETOLOGIA, 2015, 58 (04) : 654 - 665
  • [7] Receptor Tyrosine Kinase KIT: A New Look for an Old Receptor
    Ledoux, Julie
    Tchertanov, Luba
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, 2022, : 133 - 137
  • [8] Normal and oncogenic forms of the receptor tyrosine kinase kit
    Lennartsson, J
    Jelacic, T
    Linnekin, D
    Shivakrupa, R
    STEM CELLS, 2005, 23 (01) : 16 - 43
  • [9] EXPRESSION OF THE RECEPTOR TYROSINE KINASE C-KIT IN OLIGODENDROCYTE PROGENITOR CELLS
    IDA, JA
    DUBOISDALCQ, M
    MCKINNON, RD
    JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 36 (05) : 596 - 606
  • [10] Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors
    Puputti, Marjut
    Tynninen, Olli
    Pernila, Paula
    Salmi, Marko
    Jalkanen, Sirpa
    Paetau, Anders
    Sihto, Harri
    Joensuu, Heikki
    BRAIN PATHOLOGY, 2010, 20 (04) : 763 - 770